Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

US FDA advisors question usefulness of Sanofi’s combination diabetes therapy

May 24, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, US FDA, diabetes, drug trial, regulation

US Food and Drug Administration staff questioned the benefits of French drugmaker Sanofi’s (Euronext: SAN) diabetes drug candidate as well …
News
lab

French authorities pins blame on Bial and Biotrial for fatal drug trial

May 24, 2016 Manufacturing and Production, Research and Development Bial, Biotrial, France, blame, clinical trial, death, disaster, minister for health, report

Authorities in France have criticised the pharmaceutical company and the clinical research organisation at the centre of the Rennes clinical …
News
janssen_latest_logo_on_sign

Janssen’s Darzalex gets conditional European Commission approval to treat multiple myeloma

May 24, 2016 Manufacturing and Production, Research and Development, Sales and Marketing

Janssen said the European Commission (EC) conditionally approved its biologic Darzalex (daratumumab) to treat blood cancer.  The company said Daratumumab …
News
pauljenkinson

Kite Pharma names Paul Jenkinson CFO

May 23, 2016 Research and Development, Sales and Marketing appointment, cfo, kite pharma

Kite Pharma (Nasdaq: KITE) has appointed Paul Jenkinson its chief financial officer. Jenkinson succeeds Cynthia Butitta, who will continue in her role as …
Appointment
novartis_outside_1

Novartis’ heart failure drug Entresto gets top US, EU recommendation

May 23, 2016 Research and Development, Sales and Marketing Ernesto, Novartis, heart failure, regulation

Swiss drugmaker Novartis (VTX: NOVN) said its heart failure drug Entresto (sacubitril/ valsartan) has secured top recommendations in the US …
News
stocks1

Weekly Movers: Valeant, Anacor, Regeneron…

May 23, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Acorda, Aduro Biotech, Anacor Pharma, Financial, MacroGenics, Merck, Regeneron Pharma, Valeant Pharma

The earnings season came to a close with Germany’s Merck doubling its first-quarter profits. For the week, drug trials, analyst …
Feature

Bayer offers $62 billion for Monsanto in all cash deal

May 23, 2016 Research and Development, Sales and Marketing Bayer, Deals, Financial, Merger & Acquisition, monsanto

German pharma and crop sciences giant Bayer (ETR: BAYN) has made an unsolicited $62 billion all-cash offer for Monsanto Co …
News

Pfizer and Spark Therapeutics present early data on bio-engineered haemophilia drug

May 23, 2016 Research and Development, Sales and Marketing Pfizer, Spark Therapeutics, gene therapy, haemophilia B

Pfizer (NYSE: PFE) and Spark Therapeutics (NASDAQ: ONCE) have announced that they will present data showing encouraging signs in their …
News
pfizer_finland_hq

EMA to review Pfizer’s meningococcal vaccine

May 20, 2016 Research and Development, Sales and Marketing EMA, Pfizer, meningitis, meningococcal vaccine, trumenba

Pfizer (NYSE: PFE) has announced that the European Medicines Agency has accepting the marketing authorisation application for its meningococcal group …
News
money_pills_2

Horizon to acquire worldwide rights to Boehringer Ingelheim genetic disease drug

May 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, actimmune, agreement, horizon, interferon gamma-1b, worldwide rights

Horizon Pharmaceuticals (NASDAQ: HZNP) has entered into a worldwide rights agreement with Boehringer Ingelheim to acquire interferon gamma-1b, which is …
News
roche_glass_building

UK regulators do not back Roche’s breast cancer drug

May 20, 2016 Medical Communications, Research and Development, Sales and Marketing NICE, Perjeta, Roche, breast cancer, recommendation

The National Institute for Health and Care Excellence (Nice) has provisionally turned down Swiss drugmaker Roche’s (VTX: ROG) breast cancer …
News
chugai_pharmaceutical

Chugai partners with Osaka University in £62 million immunology collaboration

May 20, 2016 Medical Communications, Research and Development Chugai, collaboration, immunology, osaka university

Chugai Pharmaceuticals (TOKYO: 4519) has announced a collaboration agreement with Osaka University in advanced immunology research worth up to £62 …
News
clinical_trial_3

Celator receives FDA breakthrough therapy designation for leukaemia drug

May 20, 2016 Medical Communications, Research and Development FDA, Vyxeos, acute myeloid leukaemia, breakthrough therapy, celator

A new treatment for acute myeloid leukaemia and other blood cancers from Celator Pharmaceuticals (NASDAQ: CPXX) has been granted breakthrough …
News

Urgent action needed on antimicrobial resistance, says government report

May 19, 2016 Manufacturing and Production, Medical Communications, Research and Development ABPI, Lord Jim O'Neill, NICE, antimicrobial resistance

A new UK governmental report has warned that the global rise of antimicrobial resistance is set to worsen, with the …
News
clinical_trial_3

Darzalex meets endpoint in late-stage multiple myeloma trial

May 19, 2016 Research and Development Genmab, Janssen, daratumumab, darzalex, dexamethasone, lenalidomide, phase 3, phase III, trial

Genmab has announced that positive results from a Phase III trial evaluating Darzalex (daratumumab), which is being developed in partnership …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026